Using Luciferase Reporter Assays to Identify Functional Variants at Disease-Associated Loci.

Methods Mol Biol

Diabetes Molecular Genetics Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 445 N 5th Street, Phoenix, AZ, 85004, USA.

Published: October 2018

The genomic era, highlighted by large scale, genome-wide association studies (GWAS) for both common and rare diseases, have identified hundreds of disease-associated variants. However, most of these variants are not disease causing, but instead only provide information about a potential proximal functional variant through linkage disequilibrium. It is critical that these functional variants be identified, so that their role in disease risk can be ascertained. Luciferase assays are an invaluable tool for identifying and characterizing functional variants, allowing investigations of gene expression, intracellular signaling, transcription factors, receptor activity, and protein folding. In this chapter, we provide an overview of the different ways that luciferase assays can be used to validate functionality of a variant.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-7471-9_17DOI Listing

Publication Analysis

Top Keywords

functional variants
12
luciferase assays
8
variants
5
luciferase reporter
4
reporter assays
4
assays identify
4
functional
4
identify functional
4
variants disease-associated
4
disease-associated loci
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!